Halozyme Therapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by ProFund Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 25k | 73.34 |
| 2025-06-30 | $2.0M | 38k | 52.02 |
| 2025-03-31 | $1.7M | 27k | 63.81 |
| 2024-12-31 | $2.2M | 46k | 47.81 |
| 2024-09-30 | $2.4M | 41k | 57.24 |
| 2024-06-30 | $1.5M | 29k | 52.36 |
| 2024-03-31 | $1.7M | 41k | 40.68 |
| 2023-09-30 | $1.7M | 44k | 38.20 |
| 2023-06-30 | $1.8M | 50k | 36.07 |
| 2023-03-31 | $1.4M | 37k | 38.19 |
| 2022-12-31 | $1.3M | 23k | 56.90 |
| 2022-09-30 | $901k | 23k | 39.54 |
| 2022-06-30 | $1.0M | 23k | 43.99 |
| 2022-03-31 | $1.1M | 27k | 39.86 |
| 2021-12-31 | $1.2M | 30k | 40.22 |
| 2021-09-30 | $1.4M | 34k | 40.68 |
| 2021-06-30 | $511k | 11k | 45.53 |
| 2021-03-31 | $455k | 11k | 41.68 |
| 2020-12-31 | $531k | 12k | 42.73 |
| 2016-06-30 | $543k | 63k | 8.62 |
| 2016-03-31 | $609k | 64k | 9.47 |
| 2015-12-31 | $1.4M | 80k | 17.32 |
| 2015-09-30 | $1.1M | 80k | 13.43 |